Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
Chen S, Xie P, Cowan M, Huang H, Cardenas H, Keathley R, Tanner EJ, Fleming GF, Moroney JW, Pant A, Akasha AM, Davuluri RV, Kocherginsky M, Zhang B, Matei D.
Chen S, et al. Among authors: keathley r.
J Clin Invest. 2022 Jul 15;132(14):e158800. doi: 10.1172/JCI158800.
J Clin Invest. 2022.
PMID: 35671108
Free PMC article.
Clinical Trial.